Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
ilexoncology.com

See what CB Insights has to offer

Founded Year

1992

Stage

Acq - P2P | Acquired

Total Raised

$26.85M

About Ilex Oncology

Ilex brings novel pharmaceutical treatments for cancer patients to market, with its first drug approval in 2001. Building on the successful launch of CamPath and the initiation of clinical trials of clofarabine, Ilex is advancing an innovative pipeline of additional drug candidates.

Ilex Oncology Headquarter Location

4545 Horizon Hill Boulevard

San Antonio, Texas, 78229,

United States

210-949-8200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ilex Oncology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ilex Oncology is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.